Matches in SemOpenAlex for { <https://semopenalex.org/work/W2567139842> ?p ?o ?g. }
- W2567139842 endingPage "233" @default.
- W2567139842 startingPage "227" @default.
- W2567139842 abstract "Currently, sunitinib is a standard of care in first-line treatment for metastatic renal cell carcinoma (mRCC). However, with the standard 4/2 schedule (sunitinib 50 mg/day; 4 consecutive weeks on treatment; 2 weeks' rest), 50% of patients require dose reductions to mitigate toxicity, highlighting the need to investigate alternative dosing schedules that improve tolerability without compromising efficacy. Areas covered: We present a concise critical review of published studies comparing the efficacy and safety of the 4/2 and 2/1 schedule (2 weeks on treatment; 1 week rest) for sunitinib. While all studies evaluating the 2/1 schedule have a low level of evidence, the results indicate that the 2/1 schedule improves tolerability compared with the 4/2 schedule, including significant reductions in the incidence of specific adverse events. It was not possible to make any definitive conclusions regarding efficacy due to methodologic limitations of these studies. Expert commentary: In the absence of strong evidence supporting the safety and efficacy of the 2/1 schedule, we recommend that patients should be initiated on sunitinib therapy with the standard 4/2 schedule and only be switched to the 2/1 schedule after the development of dose-limiting toxicities from weeks 3-4 (cycle 1) of the 4/2 schedule cycle." @default.
- W2567139842 created "2017-01-06" @default.
- W2567139842 creator A5018910230 @default.
- W2567139842 creator A5020353650 @default.
- W2567139842 creator A5049672639 @default.
- W2567139842 creator A5055544489 @default.
- W2567139842 creator A5058520376 @default.
- W2567139842 creator A5061095811 @default.
- W2567139842 creator A5071984747 @default.
- W2567139842 creator A5076054848 @default.
- W2567139842 date "2017-01-03" @default.
- W2567139842 modified "2023-10-05" @default.
- W2567139842 title "How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma" @default.
- W2567139842 cites W1584237829 @default.
- W2567139842 cites W1767135729 @default.
- W2567139842 cites W1894487057 @default.
- W2567139842 cites W1899153651 @default.
- W2567139842 cites W1946476244 @default.
- W2567139842 cites W1994295819 @default.
- W2567139842 cites W1994344097 @default.
- W2567139842 cites W1995745999 @default.
- W2567139842 cites W2031614751 @default.
- W2567139842 cites W2033551302 @default.
- W2567139842 cites W2039698853 @default.
- W2567139842 cites W2061581498 @default.
- W2567139842 cites W2088386280 @default.
- W2567139842 cites W2089264350 @default.
- W2567139842 cites W2099088585 @default.
- W2567139842 cites W2103506609 @default.
- W2567139842 cites W2104675861 @default.
- W2567139842 cites W2107103442 @default.
- W2567139842 cites W2112075556 @default.
- W2567139842 cites W2113788015 @default.
- W2567139842 cites W2116949558 @default.
- W2567139842 cites W2117125017 @default.
- W2567139842 cites W2141444851 @default.
- W2567139842 cites W2143782771 @default.
- W2567139842 cites W2149032069 @default.
- W2567139842 cites W2149456801 @default.
- W2567139842 cites W2149613039 @default.
- W2567139842 cites W2150955627 @default.
- W2567139842 cites W2153331460 @default.
- W2567139842 cites W2155319477 @default.
- W2567139842 cites W2156114777 @default.
- W2567139842 cites W2158496491 @default.
- W2567139842 cites W2160120519 @default.
- W2567139842 cites W2164886552 @default.
- W2567139842 cites W2165094466 @default.
- W2567139842 cites W2207224549 @default.
- W2567139842 cites W2345707108 @default.
- W2567139842 cites W4229769653 @default.
- W2567139842 doi "https://doi.org/10.1080/14737140.2017.1276830" @default.
- W2567139842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28044472" @default.
- W2567139842 hasPublicationYear "2017" @default.
- W2567139842 type Work @default.
- W2567139842 sameAs 2567139842 @default.
- W2567139842 citedByCount "10" @default.
- W2567139842 countsByYear W25671398422017 @default.
- W2567139842 countsByYear W25671398422018 @default.
- W2567139842 countsByYear W25671398422019 @default.
- W2567139842 countsByYear W25671398422020 @default.
- W2567139842 countsByYear W25671398422021 @default.
- W2567139842 countsByYear W25671398422022 @default.
- W2567139842 crossrefType "journal-article" @default.
- W2567139842 hasAuthorship W2567139842A5018910230 @default.
- W2567139842 hasAuthorship W2567139842A5020353650 @default.
- W2567139842 hasAuthorship W2567139842A5049672639 @default.
- W2567139842 hasAuthorship W2567139842A5055544489 @default.
- W2567139842 hasAuthorship W2567139842A5058520376 @default.
- W2567139842 hasAuthorship W2567139842A5061095811 @default.
- W2567139842 hasAuthorship W2567139842A5071984747 @default.
- W2567139842 hasAuthorship W2567139842A5076054848 @default.
- W2567139842 hasConcept C111919701 @default.
- W2567139842 hasConcept C126322002 @default.
- W2567139842 hasConcept C143998085 @default.
- W2567139842 hasConcept C197934379 @default.
- W2567139842 hasConcept C2777288759 @default.
- W2567139842 hasConcept C2777472916 @default.
- W2567139842 hasConcept C2778375690 @default.
- W2567139842 hasConcept C2779490328 @default.
- W2567139842 hasConcept C41008148 @default.
- W2567139842 hasConcept C68387754 @default.
- W2567139842 hasConcept C71924100 @default.
- W2567139842 hasConceptScore W2567139842C111919701 @default.
- W2567139842 hasConceptScore W2567139842C126322002 @default.
- W2567139842 hasConceptScore W2567139842C143998085 @default.
- W2567139842 hasConceptScore W2567139842C197934379 @default.
- W2567139842 hasConceptScore W2567139842C2777288759 @default.
- W2567139842 hasConceptScore W2567139842C2777472916 @default.
- W2567139842 hasConceptScore W2567139842C2778375690 @default.
- W2567139842 hasConceptScore W2567139842C2779490328 @default.
- W2567139842 hasConceptScore W2567139842C41008148 @default.
- W2567139842 hasConceptScore W2567139842C68387754 @default.
- W2567139842 hasConceptScore W2567139842C71924100 @default.
- W2567139842 hasFunder F4320307765 @default.
- W2567139842 hasIssue "3" @default.
- W2567139842 hasLocation W25671398421 @default.
- W2567139842 hasLocation W25671398422 @default.